BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34599256)

  • 1. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening.
    Krigul KL; Aasmets O; Lüll K; Org T; Org E
    Sci Rep; 2021 Oct; 11(1):19603. PubMed ID: 34599256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
    Chen H; Werner S; Brenner H
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program.
    Brezina S; Borkovec M; Baierl A; Bastian F; Futschik A; Gasche N; Gruenberger T; Hallas M; Jannsen C; Leeb G; Lutz R; Sladek B; Gsur A
    Gut Microbes; 2023; 15(1):2176119. PubMed ID: 36794815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
    Baxter NT; Koumpouras CC; Rogers MA; Ruffin MT; Schloss PD
    Microbiome; 2016 Nov; 4(1):59. PubMed ID: 27842559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
    Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Fecal Sample Collection Methods for Microbial Analysis Embedded within Colorectal Cancer Screening Programs.
    Zouiouich S; Mariadassou M; Rué O; Vogtmann E; Huybrechts I; Severi G; Boutron-Ruault MC; Senore C; Naccarati A; Mengozzi G; Kozlakidis Z; Jenab M; Sinha R; Gunter MJ; Leclerc M
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):305-314. PubMed ID: 34782392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy.
    Young C; Wood HM; Fuentes Balaguer A; Bottomley D; Gallop N; Wilkinson L; Benton SC; Brealey M; John C; Burtonwood C; Thompson KN; Yan Y; Barrett JH; Morris EJA; Huttenhower C; Quirke P
    Clin Cancer Res; 2021 Apr; 27(8):2246-2254. PubMed ID: 33658300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants.
    Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB
    BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reusing a prepaid health plan's fecal immunochemical tests for microbiome associations with colorectal adenoma.
    Goedert JJ; Wu Z; Yonehara CH; Frankland TB; Sinha R; Jones GS; Wan Y; Ravel J; Zhao N; Honda SA
    Sci Rep; 2022 Aug; 12(1):14801. PubMed ID: 36045142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study.
    Goedert JJ; Gong Y; Hua X; Zhong H; He Y; Peng P; Yu G; Wang W; Ravel J; Shi J; Zheng Y
    EBioMedicine; 2015 Jun; 2(6):597-603. PubMed ID: 26288821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Methods To Collect Fecal Samples for Microbiome Studies Using Whole-Genome Shotgun Metagenomic Sequencing.
    Byrd DA; Sinha R; Hoffman KL; Chen J; Hua X; Shi J; Chia N; Petrosino J; Vogtmann E
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32250964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of fecal microbiota for early-stage detection of colorectal cancer.
    Zeller G; Tap J; Voigt AY; Sunagawa S; Kultima JR; Costea PI; Amiot A; Böhm J; Brunetti F; Habermann N; Hercog R; Koch M; Luciani A; Mende DR; Schneider MA; Schrotz-King P; Tournigand C; Tran Van Nhieu J; Yamada T; Zimmermann J; Benes V; Kloor M; Ulrich CM; von Knebel Doeberitz M; Sobhani I; Bork P
    Mol Syst Biol; 2014 Nov; 10(11):766. PubMed ID: 25432777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collection of non-meconium stool on fecal occult blood cards is an effective method for fecal microbiota studies in infants.
    Wong WSW; Clemency N; Klein E; Provenzano M; Iyer R; Niederhuber JE; Hourigan SK
    Microbiome; 2017 Sep; 5(1):114. PubMed ID: 28870234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma.
    Zhang Y; Lu M; Lu B; Liu C; Ma Y; Liu L; Miao X; Qin J; Chen H; Dai M
    Clin Transl Gastroenterol; 2021 Aug; 12(8):e00389. PubMed ID: 34408121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating gut microbiota profiles from archived fecal samples.
    Rounge TB; Meisal R; Nordby JI; Ambur OH; de Lange T; Hoff G
    BMC Gastroenterol; 2018 Nov; 18(1):171. PubMed ID: 30409123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests.
    Gies A; Gruner LF; Schrotz-King P; Brenner H
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1829-1839.e4. PubMed ID: 30851476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries.
    Young C; Wood HM; Seshadri RA; Van Nang P; Vaccaro C; Melendez LC; Bose M; Van Doi M; Piñero TA; Valladares CT; Arguero J; Balaguer AF; Thompson KN; Yan Y; Huttenhower C; Quirke P
    Genome Med; 2021 Feb; 13(1):27. PubMed ID: 33593386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.